Discontinued — last reported Q3 '16
KLA Corporation Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 1.6% to $14.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 57.9%, from $35.13M to $14.80M. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $182.07M | $182.27M | $204.89M | $129.63M | $129.63M | $129.63M | $49.73M | $49.03M | $48.85M | $34.53M | $35.13M | $35.24M | $14.56M | $14.80M |
| QoQ Change | — | +0.1% | +12.4% | -36.7% | +0.0% | +0.0% | -61.6% | -1.4% | -0.4% | -29.3% | +1.7% | +0.3% | -58.7% | +1.6% |
| YoY Change | — | — | — | -28.8% | -28.9% | -36.7% | -61.6% | -62.2% | -62.3% | -30.6% | -28.3% | -27.9% | -57.8% | -57.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.